Skip to main content
Signal8

Steik Jason Paul

SEC insider (Form 3/4/5 filer). CIK 0002078374. Chief Clinical Officer at Pennant Group, Inc. (PNTG). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in EAGLE, ID.

Companies Steik Jason Paul has filed insider reports for

  • Pennant Group, Inc. (PNTG): Officer, Chief Clinical Officer
Steik Jason Paul profile photo

Steik Jason Paul

CIK: 0002078374

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Pennant Group, Inc. logo
PNTG

Pennant Group, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Pennant Group, Inc. logo
    PNTG

    Pennant Group, Inc.

    Aug 6, 2026
    Sale
    Direct
    1.4K shares at avg. $38.52$54K
  • Pennant Group, Inc. logo
    PNTG

    Pennant Group, Inc.

    Mar 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    26K shares at avg. $33.30-

1-2 of 2